These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 28263753)
1. The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study. Romero R; Erez O; Maymon E; Chaemsaithong P; Xu Z; Pacora P; Chaiworapongsa T; Done B; Hassan SS; Tarca AL Am J Obstet Gynecol; 2017 Jul; 217(1):67.e1-67.e21. PubMed ID: 28263753 [TBL] [Abstract][Full Text] [Related]
2. A proteomic clock of human pregnancy. Aghaeepour N; Lehallier B; Baca Q; Ganio EA; Wong RJ; Ghaemi MS; Culos A; El-Sayed YY; Blumenfeld YJ; Druzin ML; Winn VD; Gibbs RS; Tibshirani R; Shaw GM; Stevenson DK; Gaudilliere B; Angst MS Am J Obstet Gynecol; 2018 Mar; 218(3):347.e1-347.e14. PubMed ID: 29277631 [TBL] [Abstract][Full Text] [Related]
3. The prediction of early preeclampsia: Results from a longitudinal proteomics study. Tarca AL; Romero R; Benshalom-Tirosh N; Than NG; Gudicha DW; Done B; Pacora P; Chaiworapongsa T; Panaitescu B; Tirosh D; Gomez-Lopez N; Draghici S; Hassan SS; Erez O PLoS One; 2019; 14(6):e0217273. PubMed ID: 31163045 [TBL] [Abstract][Full Text] [Related]
4. The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study. Erez O; Romero R; Maymon E; Chaemsaithong P; Done B; Pacora P; Panaitescu B; Chaiworapongsa T; Hassan SS; Tarca AL PLoS One; 2017; 12(7):e0181468. PubMed ID: 28738067 [TBL] [Abstract][Full Text] [Related]
5. The amniotic fluid proteome changes with gestational age in normal pregnancy: a cross-sectional study. Bhatti G; Romero R; Gomez-Lopez N; Chaiworapongsa T; Jung E; Gotsch F; Pique-Regi R; Pacora P; Hsu CD; Kavdia M; Tarca AL Sci Rep; 2022 Jan; 12(1):601. PubMed ID: 35022423 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal profiles of plasma eicosanoids during pregnancy and size for gestational age at delivery: A nested case-control study. Welch BM; Keil AP; van 't Erve TJ; Deterding LJ; Williams JG; Lih FB; Cantonwine DE; McElrath TF; Ferguson KK PLoS Med; 2020 Aug; 17(8):e1003271. PubMed ID: 32797061 [TBL] [Abstract][Full Text] [Related]
7. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241 [TBL] [Abstract][Full Text] [Related]
8. Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. Korzeniewski SJ; Romero R; Chaiworapongsa T; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L Am J Obstet Gynecol; 2016 May; 214(5):629.e1-629.e17. PubMed ID: 26688491 [TBL] [Abstract][Full Text] [Related]
10. Case-control study of prolactin and placental lactogen in SGA pregnancies. Ladyman SR; Larsen CM; Taylor RS; Grattan DR; McCowan LME Reprod Fertil; 2021 Dec; 2(4):244-250. PubMed ID: 35118402 [TBL] [Abstract][Full Text] [Related]
11. Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both. Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Bardani E; Nicolaides KH Ultrasound Obstet Gynecol; 2020 Sep; 56(3):408-415. PubMed ID: 32621353 [TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
13. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study. Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477 [TBL] [Abstract][Full Text] [Related]
14. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382 [TBL] [Abstract][Full Text] [Related]
15. Association between the fetal cerebroplacental ratio and biomarkers of hypoxia and angiogenesis in the maternal circulation at term. Irvine KM; Bligh LN; Kumar S Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():198-204. PubMed ID: 31889569 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia. Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal Proteomic Analysis of Plasma across Healthy Pregnancies Reveals Indicators of Gestational Age. Yohannes E; Ippolito DL; Damicis JR; Dornisch EM; Leonard KM; Napolitano PG; Ieronimakis N Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806078 [TBL] [Abstract][Full Text] [Related]
18. Placenta-derived proteins across gestation in healthy pregnancies-a novel approach to assess placental function? Degnes ML; Westerberg AC; Zucknick M; Powell TL; Jansson T; Henriksen T; Roland MCP; Michelsen TM BMC Med; 2022 Jul; 20(1):227. PubMed ID: 35773701 [TBL] [Abstract][Full Text] [Related]
19. The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio). Chaiworapongsa T; Romero R; Erez O; Tarca AL; Conde-Agudelo A; Chaemsaithong P; Kim CJ; Kim YM; Kim JS; Yoon BH; Hassan SS; Yeo L; Korzeniewski SJ Am J Obstet Gynecol; 2017 Dec; 217(6):682.e1-682.e13. PubMed ID: 29037482 [TBL] [Abstract][Full Text] [Related]
20. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. Erez O; Romero R; Espinoza J; Fu W; Todem D; Kusanovic JP; Gotsch F; Edwin S; Nien JK; Chaiworapongsa T; Mittal P; Mazaki-Tovi S; Than NG; Gomez R; Hassan SS J Matern Fetal Neonatal Med; 2008 May; 21(5):279-87. PubMed ID: 18446652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]